Clin Osteol 2020; 25(2): 83-84

Definice osteoporotické (křehké) zlomeniny: stanovisko Společnosti pro metabolická onemocnění skeletu České lékařské společnosti J. E. Purkyně (SMOS ČLS JEP)Guidelines

Pikner Richard1,2,3, Palička Vladimír4, Vyskočil Václav5, Zikán Vít6, Rosa Jan7, Kasalický Petr7, Horák Pavel7, Jenšovský Jiří8, Šenk František9, Bayer Milan10, Kutílek Štěpán6, Kuba Vít11, Broulík Petr6
1 Oddělení klinických laboratoří, pracoviště kostního metabolizmu, Klatovská nemocnice a. s., Klatovy
2 Ústav klinické biochemie a hematologie LF UK a FN Plzeň
3 Katedra záchranářství, diagnostických oborů a veřejného zdravotnictví, Fakulta zdravotnických studií 
Západočeské univerzity v Plzni
4 Ústav klinické biochemie a diagnostiky LF UK a FN Hradec Králové
5 Osteocentrum, II. interní klinika LF UK a FN Plzeň
6 Ambulance pro metabolická onemocnění skeletu a poruchy kalciového metabolismu, III. interní klinika 1. LF UK a VFN v Praze
7 Osteocentrum, Affidea Praha s. r. o., Praha
8 Interní klinika 1. LF UK a ÚVN - Vojenská fakultní nemocnice Praha
9 Osteocentrum, Nemocnice Havlíčkův Brod
10 Dětská klinika LF UK a FN Hradec Králové
11 Nemocnice Chomutov, o. z. - Krajská zdravotní, a. s., Chomutov

Received: February 9, 2020; Published: December 11, 2020  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Pikner R, Palička V, Vyskočil V, Zikán V, Jan R, Kasalický P, et al.. Definice osteoporotické (křehké) zlomeniny: stanovisko Společnosti pro metabolická onemocnění skeletu České lékařské společnosti J. E. Purkyně (SMOS ČLS JEP). Clinical Osteology. 2020;25(2):83-84.
Share...
Download citation
  • BibTeX (.bib)
  • Bookends (.ris)
  • EasyBib (.ris)
  • EndNote (.enw)
  • EndNote 8 (.xml)
  • ISI WoS (.isi)
  • Medlars (.medlars)
  • Mendeley (.ris)
  • MODS (.xml)
  • Papers (.ris)
  • RefWorks (.txt)
  • RefManager (.ris)
  • RIS (.ris)
  • MS Word (.xml)
  • Zotero (.ris)
    • Open full article

    References

    1. [World Health Organization]. Assessment of fracture risk and its application to screening for postmenopausal osteoporosis: report of a WHO study group (Rome from 22 to 25 June 1992). Dostupné z WWW: <https://apps.who.int/iris/handle/10665/39142>.
    2. Kanis JA, Johansson H, Cooper C et al. European guidance for the diagnosis and management of osteoporosis in postmenopausal women. Osteoporos Int 2013; 24(1): 23-57. Dostupné z DOI: <https://doi.org/10.1007/s00198-012-2074-y>. Go to original source...
    3. [World Health Organization]. Guidelines for preclinical evaluation and clinical trials in osteoporosis. World Health Organization Geneva 1998. Dostupné z WWW: <https://apps.who.int/iris/bitstream/handle/10665/42088/9241545224_eng.pdf?sequence=1&isAllowed=y>.
    4. Brown JP, Josse RG et al. 2002 clinical practice guidelines for the diagnosis and management of osteoporosis in Canada. CMAJ 2002;167(10 Suppl): S1-S34.
    5. Vanasse A, Dagenais P, Niyonsenga T et al. Bone mineral density measurement and osteoporosis treatment after a fragility fracture in older adults: regional variation and determinants of use in Quebec. BMC Musculoskelet Disord 2005; 6 : 33. Dostupné z DOI: <https://doi.org/10.1186/1471-2474-6-33>. Go to original source...
    6. Warriner AH, Patkar NM, Curtis JR et al. Which Fractures Are Most Attributable to Osteoporosis? J Clin Epidemiol 2011; 64(1): 46-53. Dostupné z DOI: <https://doi.org/10.1016/j.jclinepi.2010.07.007>. Go to original source...
    7. Kanis JA [WHO Scientific Group 2007]. Assessment of osteoporosis at the primary healthcare level. Dostupné z WWW: <https://www.who.int/chp/topics/Osteoporosis.pdf>.
    8. Melton LJ, Thamer M, Ray NF et al. Fractures Attributable to Osteoporosis: Report from the National Osteoporosis Foundation. J Bone Miner Res 1997; 12(1): 16-23. Dostupné z DOI: <https://doi.org/10.1359/jbmr.1997.12.1.16>. Go to original source...

    Return to the content


    Clinical Osteology

    Madam, Sir,
    please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
    Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

    I declare:

    1. that I have met the above instruction
    2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited

    No
    Yes

    If your statement is not true, please be aware
    that brings the risk of danger to their health or the health of others.